खोज परिणाम - Investigators

  1. 1

    Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023 द्वारा on behalf of the PROMISE investigators

    प्रकाशित 2025-06-01

    BACKGROUND Respiratory syncytial virus (RSV) is a major cause of morbidity in older adults. AIM We aimed to investigate the epidemiology of RSV in adults in five European countries and one region before and during the COVID-19 era. METHODS We conducted a retrospective analysis using national hospita...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  2. 2

    Clinical phenotyping of cardiogenic shock at a glance: A rapid, costless, streamlined approach द्वारा Miloud Cherbi, Hamid Merdji, Eric Bonnefoy, François Roubille, Clément Delmas, for the FRENSHOCK Investigators

    प्रकाशित 2025-08-01

    Abstract Aims Cardiogenic shock (CS) is a heterogeneous syndrome in which recent guidelines have proposed clinical phenotyping based on the presence of hypoperfusion and/or congestion signs and symptoms. However, the impact of this clinical phenotype on outcomes remains poorly characterized. Methods...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  3. 3

    Association of Knee Pain Frequency and Severity with Quadriceps Strength but Not Rate of Decline Over Four Years द्वारा David A. Sherman, Tuhina Neogi, Samantha Hornsby, David Felson, Michaell Lavalley, Joshua J. Stefanik, for the OAI investigators

    प्रकाशित 2025-07-01

    Objective Quadriceps weakness increases the risk of knee osteoarthritis (OA) and functional decline. Understanding how quadriceps strength changes over time is crucial for managing knee OA. Knee pain and effusion may influence strength over time through inhibition of motor pathways, but this remains...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  4. 4
  5. 5

    Comparison of Clinical Scores for Predicting Stroke‐Associated Pneumonia After Acute Ischemic Stroke द्वारा Linlin Wang, Jun Xu, Xinyu Liu, Feifei Ma, Xingquan Zhao, Anxin Wang, Ruijun Ji, Yongjun Wang, CNSR III investigators

    प्रकाशित 2025-04-01

    ABSTRACT Objectives To compare the discrimination and calibration of six risk scoring systems in the assessment of patients with stroke‐associated pneumonia (SAP) after acute ischemic stroke. Methods The validation cohort was derived from the Third China National Stroke Registry. SAP was diagnosed a...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  6. 6

    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model. द्वारा Beom Joon Kim, Beom Joon Kim, Keon-Joo Lee, Eun Lyeong Park, Kanta Tanaka, Masatoshi Koga, Sohei Yoshimura, Ryo Itabashi, Jae-Kwan Cha, Byung-Chul Lee, Hisanao Akiyama, Yoshinari Nagakane, Juneyoung Lee, Kazunori Toyoda, SAMURAI Study Investigators, Hee-Joon Bae, CRCS-K Investigators

    प्रकाशित 2021-01-01

    <h4>Background</h4>There is currently no validated risk prediction model for recurrent events among patients with acute ischemic stroke (AIS) and atrial fibrillation (AF). Considering that the application of conventional risk scores has contextual limitations, new strategies are needed t...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  7. 7

    A systematic review of evidence regarding the association between time to mobilization following hip fracture surgery and patient outcomes द्वारा Veena Mazarello Paes, Andrew Ting, James Masters, Mahalia V. I. Paes, Simon Mathew Graham, Matthew L. Costa, On behalf of the HIPCARE investigators*

    प्रकाशित 2025-07-01

    Aims: Performance indicators are increasingly used to evaluate the quality of healthcare provided to patients following a hip fracture. In this systematic review, we investigated the association between ‘early mobilization’ after surgery and patient outcomes. Methods: Evidence was searched through 1...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  8. 8

    Exploration of alive-and-ventilator free days as an outcome measure for clinical trials of Resuscitative interventions. द्वारा Ari Moskowitz, Xianhong Xie, Michelle Ng Gong, Henry E Wang, Luke Andrea, Yungtai Lo, Mimi Kim, Hospital Airway Resuscitation Trial Investigators

    प्रकाशित 2024-01-01

    <h4>Background</h4>Outcome selection is a critically important aspect of clinical trial design. Alive-and-ventilator free days is an outcome measure commonly used in critical care clinical trials, but has not been fully explored in resuscitation science.<h4>Methods</h4>A simu...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  9. 9

    Pharmacometabolomics Study of Sulfamethoxazole and Trimethoprim in Kidney Transplant Recipients: Real-World Metabolism and Urinary Excretion द्वारा Marieke A. J. Hof, Hessel de Haan, Stepan Stepanovic, Stephan J. L. Bakker, Eelko Hak, Gérard Hopfgartner, Frank Klont, TransplantLines Investigators

    प्रकाशित 2025-07-01

    <b>Background/Objectives</b>: The increased use of antibiotics is raising concerns about environmental contamination and antibiotic resistance, exemplified by the case of cotrimoxazole, a widely prescribed combination of sulfamethoxazole and trimethoprim. After oral administration and ab...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  10. 10

    Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study. द्वारा Adam Green, Jean-Sebastien Rachoin, Christa Schorr, Phil Dellinger, Jonathan D Casey, Isabel Park, Shruti Gupta, Rebecca M Baron, Shahzad Shaefi, Krystal Hunter, David E Leaf, STOP-COVID Investigators

    प्रकाशित 2023-01-01

    <h4>Purpose</h4>To investigate if the timing of initiation of invasive mechanical ventilation (IMV) for critically ill patients with COVID-19 is associated with mortality.<h4>Materials and methods</h4>The data for this study were derived from a multicenter cohort study of cri...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  11. 11

    Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma—Is There a Difference? द्वारा Beathe Kiland Granerud, Mari Kaarbø, Huda Al-Baldawi, The Norwegian SARS-CoV-2 Study Group Investigators, Kari Otterdal, Bente Halvorsen, Andreas Lind, Simon Rayner, Jan Cato Holter, Susanne Dudman

    प्रकाशित 2025-05-01

    The aim of this study is to ascertain whether qRT-PCR (reverse transcriptase real-time PCR) or RT-ddPCR (reverse transcriptase digital droplet PCR) is more effective for detecting SARS-CoV-2 RNA (severe acute respiratory syndrome coronavirus 2 RNA) in blood plasma from COVID-19 (coronavirus infectio...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  12. 12

    Pharmacological Strategies for Providing Patients With Delirium Relief From Terminal Dyspnea: A Secondary Data Analysis द्वारा Takaaki Hasegawa, Masanori Mori, Takashi Yamaguchi, Kengo Imai, Yoshinobu Matsuda, Isseki Maeda, Yutaka Hatano, Naosuke Yokomichi, Jun Hamano, Tatsuya Morita, East Asian Collaborative Cross‐Cultural Study to Elucidate the Dying Process (EASED) investigators

    प्रकाशित 2025-02-01

    ABSTRACT Introduction Systemic opioids are recommended as a pharmacological treatment for dyspnea, and antipsychotics are widely used for delirium. Because little is known about optimal palliative pharmacological strategies for dyspnea in patients with delirium, this study explored the symptom cours...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  13. 13

    Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction. द्वारा Ki Yung Boo, Miyeon Kim, Jae-Geun Lee, Geum Ko, Joon Hyouk Choi, Song-Yi Kim, Seung-Jae Joo, Jin-Yong Hwang, Seung-Ho Hur, Kwang Soo Cha, Myung Ho Jeong, KAMIR-NIH registry investigators

    प्रकाशित 2025-01-01

    Beta-blockers have been considered the cornerstone of treatment for patients with acute myocardial infarction (AMI). However, long-term benefits of vasodilating beta-blockers remain uncertain. This study aimed to investigate the long-term clinical benefits of vasodilating beta-blockers compared to c...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  14. 14
  15. 15

    European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD). द्वारा Ekaterina Krauss, Laurenz H Claas, Silke Tello, Jennifer Naumann, Sandra Wobisch, Stefan Kuhn, Raphael W Majeed, Karen Moor, Maria Molina-Molina, Oisin Byrne, Rebecca Borton, Marlies S Wijsenbeek, Nik Hirani, Carlo Vancheri, Bruno Crestani, Andreas Guenther, eurILDreg investigators

    प्रकाशित 2025-01-01

    <h4>Background and aims</h4>Predicting progression and prognosis in Interstitial Lung Diseases (ILD), especially Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF), remains a challenge. Integrating patient-centered measurements is essential for earlier and safer...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  16. 16

    Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF द्वारा Robert Shaddy, Jianjian Gong, Tania Garito, Susan Solar‐Yohay, Sijia Zhang, Margaret F. Prescott, Damien Bonnet, Paul F. Kantor, Michael Burch, Chad Mao, Antoinette Cilliers, Charles Canter, Yuk Law, Giorgia Grutter, Jou Kou Wang, Aamir Jeewa, Joseph Rossano, PANORAMA‐HF investigators

    प्रकाशित 2025-08-01

    Abstract Aims The PANORAMA‐HF trial demonstrated significant N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) reductions in paediatric patients with left ventricular systolic dysfunction with sacubitril/valsartan or enalapril treatment over 52 weeks. This post hoc analysis aims to correlate cha...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  17. 17

    Hospitalizations among adults with chronic kidney disease in the United States: A cohort study. द्वारा Sarah J Schrauben, Hsiang-Yu Chen, Eugene Lin, Christopher Jepson, Wei Yang, Julia J Scialla, Michael J Fischer, James P Lash, Jeffrey C Fink, L Lee Hamm, Radhika Kanthety, Mahboob Rahman, Harold I Feldman, Amanda H Anderson, CRIC Study Investigators

    प्रकाशित 2020-12-01

    <h4>Background</h4>Adults with chronic kidney disease (CKD) are hospitalized more frequently than those without CKD, but the magnitude of this excess morbidity and the factors associated with hospitalizations are not well known.<h4>Methods and findings</h4>Data from 3,939 par...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  18. 18

    The opportunity to save a life: A qualitative study of a point-of-care overdose education and naloxone distribution intervention. द्वारा Janet A Parsons, Benjamin Markowitz, Rekha Thomas, Kris Norris, Mercy Charles, Chantelle King, Kate Sellen, Douglas M Campbell, Pamela Leece, Michelle Klaiman, Leigh Chapman, Shaun Hopkins, Rita Shahin, Curtis Handford, Vicky Stergiopoulos, Laurie J Morrison, Carol Strike, Aaron M Orkin, SOONER investigators

    प्रकाशित 2025-01-01

    Canada's opioid crisis continues to escalate. Naloxone can effectively reverse the effects of opioid overdose. We planned a randomized trial on the effectiveness of a point-of-care overdose education and naloxone distribution (OEND) intervention on participants' performance in a simulated...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  19. 19

    XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease द्वारा Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Georg Leinenkugel, Claudia Krieger, Samuel Truniger, Annett Franke, Seraina Koller, Katline Metzger-Peter, Nicola Frei, STAR SIGN Study Investigators, Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Wolfgang Korte, Justus J. Bürgi, Stephan Brand

    प्रकाशित 2025-07-01

    Background: Mucosal immunity plays a pivotal role in preventing infections with SARS-CoV-2. While COVID-19 mRNA vaccines induce robust systemic immune responses in patients with inflammatory bowel disease (IBD), little is known about their efficacy in the mucosal immune compartment. In this sub-inve...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  20. 20

    Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry द्वारा Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, Altshock‐2 investigators

    प्रकाशित 2025-08-01

    Abstract Aims We aimed to assess the impact of pre‐admission beta‐blocker (BB) therapy on the clinical characteristics, in‐hospital treatment and outcomes of patients with cardiogenic shock (CS). Methods All patients enrolled in the multicentre prospective Altshock‐2 registry since March 2020 with a...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख